Home > News > Top Stories > Performant Capital Creates Platform Delivering Managed Technology Services and Revenue Cycle Management to the Healthcare Industry

Health Technology

Performant Capital Creates Platform Delivering Managed Technology Services and Revenue Cycle Management to the Healthcare Industry

Performant Capital announced that it has formed Provider Technology, LLC through the acquisitions of DavLong Business Solutions LLC and its affiliate Administrative Advantage LLC and On Demand Solutions Inc. Provider Technology is a leading technology provider of outsourced software and IT services, revenue cycle management (“RCM”) and back-office business support primarily to physician practices and health systems. The businesses will continue to operate independently under their respective brands but share best practices across all functional areas.

Performant, investing out of Fund I, closed the DBS and ODS transactions simultaneously in June. The Private Credit business within Goldman Sachs Asset Management provided first lien debt and an equity co-investment to support the acquisitions.

“The team at Goldman Sachs has been invaluable as we executed this platform investment. We look forward to meaningfully accelerating the growth of the business given the scale enabled by Goldman’s partnership.”

Mike Ciaglia, Partner at Performant

Founded in 1983 and headquartered in Savannah, GA, DBS provides turnkey IT solutions for physician practices by fully hosting, maintaining, and supporting all software needs for the medical office, from cloud hosting to cybersecurity. DBS combines its proprietary suite of software offerings with leading third-party solutions to provide medical practices with a fully integrated electronic health record and practice management system from a single vendor. In addition to its best-in-class software offering, DBS also provides complete RCM services designed to manage and optimize the entire collections process for practices. Across both primary functional areas, the company leverages technology, analytics, and the expertise of its skilled teams to improve operational and financial performance for customers.

Founded in 2007 and headquartered in Boise, ID, ODS provides practice management software, RCM, staffing support and business advisory services to healthcare service providers and organizations. Its solutions improve business operational efficiency, reduce administrative costs, and assure managerial control so clients can stay focused on providing quality patient care.

The combination of DBS, AA, and ODS creates a national back-office and healthcare technology platform servicing more than 3,000 medical providers across the U.S and across medical specialties – developing best-in-class offerings and technology for specific specialties, such as Ophthalmology, EMS and Hospitalist providers. “These businesses are highly complementary acquisitions that together provide enhanced technology capabilities and support services with broader geographic presence to better meet the needs of clients and improve their financial outcomes,” said Chris McLaughlin, Partner at Performant Capital. “Both businesses have a reputation of providing superior customer support as value-added partners to physicians and health organizations. Customers value our company as more than just a service provider, but extensions of their core teams. With an expanded presence and enhanced capabilities to drive further value for clients, we’re excited about the future of the combined business under Provider Technology.”

Provider Technology continues to look for best-in-class revenue cycle management and managed service provider software businesses to healthcare customers that would expand its geographic footprint and service capabilities. If you have an opportunity that might be an add-on acquisition candidate for Provider Technology, please contact Mike Ciaglia.

About Performant Capital
Performant Capital is a Chicago-based, lower middle market private equity firm focused on investments in technology-driven companies. Performant acquires businesses across SaaS, technology-enabled services, and data intelligence products and services. With over 50 years of collective investing and operating experience in these sectors, Performant’s principals seek opportunities where its depth of investing, operating expertise, and partner network can materially impact performance. More information on Performant Capital can be found at www.performantcapital.com.

About Goldman Sachs Asset Management Private Credit
Bringing together traditional and alternative investments, Goldman Sachs Asset Management provides clients around the world with a dedicated partnership and focus on long-term performance. As the primary investing area within Goldman Sachs it delivers investment and advisory services for the world’s leading institutions, financial advisors and individuals, drawing from its deeply connected global network and tailored expert insights, across every region and market—overseeing more than $2 trillion in assets under supervision worldwide as of March 31, 2022. Driven by a passion for its clients’ performance, it seeks to build long-term relationships based on conviction, sustainable outcomes, and shared success over time. Goldman Sachs Asset Management invests in the full spectrum of alternatives, including private equity, growth equity, private credit, real estate and infrastructure. Established in 1996, the Private Credit business within Goldman Sachs Asset Management is one of the world’s largest private credit investors with over $90 billion in assets across direct lending, mezzanine debt, hybrid capital and asset-based lending strategies. Its deep industry and product knowledge, extensive relationships and global footprint position it to deliver scaled outcomes with speed and certainty, supporting companies from the lower middle market to large cap in size.

Spotlight

More featured news

Spotlight

Related News

Health Technology, Digital Healthcare

Applications Open for Johnson & Johnson's Second Health Equity Innovation Challenge

PR Newswire | October 04, 2023

Johnson & Johnsonannounced applications for the 2023 - 2024 Health Equity Innovation Challenge are officially open in five U.S. cities: Atlanta, Chicago, Los Angeles, New York City and Philadelphia. These geographic areas were selected due to demonstrated need for healthcare education, access and care. Created in 2021 as a part of Johnson & Johnson's commitment to help eradicate the public health threats of racial and social injustices, the Challenge aims to support healthcare solutions developed by local entrepreneurs, start-ups and community-based organizations that are working to advance health equity among communities of color. "At the heart of our commitment to health equity is a desire to create a world in which access to care, quality of care and health outcomes isn't determined by the color of a person's skin," says Howard Reid, Global Head, Global Public Health and Social Impact at Johnson & Johnson. The Health Equity Innovation Challenge shines a light on health inequities and supports innovators at the local level to create solutions that empower individuals of color and strengthen our health systems. [Source: PR Newswire] With applications open through November 6, the Health Equity Innovation Challenge invites local innovators, entrepreneurs and community-based organizations to submit their ideas on how to prevent and treat illnesses disproportionately affecting communities of color, enhance equitable access to healthcare, stimulate diversity in science, advocate for more trusted community-based healthcare, and promote health equity through community engagement and education. An independent panel of renowned public health and health equity experts with diverse experience in healthcare delivery, advocacy, entrepreneurship and academia will review the applications. The panel includes Cato T. Laurencin, M.D., Ph.D.; Eddie Martinez; HEIC Chairperson Helene Gayle, M.D.; Kathryn Finney; Kiera Smalls; and Uché Blackstock, M.D. In addition to the panel of expert judges, select individuals appointed by the Challenge's academic partner, Spelman College, will review and screen the applications. In 2024, Johnson & Johnson will grant five Awardees up to $75,000 each in seed funding to further the impact of their innovations. Awardees will also have the opportunity to be mentored by industry leaders, gain visibility for their work and have access to the Johnson & Johnson Innovation – JLABS ecosystem, which provides educational programming, and networking opportunities. "Johnson & Johnson is committed to cultivating solutions that help close the racial health gap," says Reid. "We know that those closest to the challenges are often best positioned to create the most effective solutions. We are excited to accelerate innovative approaches that result in healthier outcomes for people of color through this Challenge."

Health Technology, Medical Devices

GE HealthCare Receives FDA Clearance of Allia IGS Pulse - the Next Generation of Image-Guided Systems Designed for Cardiac Imaging Excellence

Business Wire | October 18, 2023

GE HealthCare announced US FDA 510(k) clearance of Allia IGS Pulse - the latest addition to the company’s image guided system (IGS) offerings. Allia IGS Pulse features a new imaging chain engineered to provide exceptional imaging at the right dose for visible impact in complex cardiology interventions regardless of patient size. In modern healthcare today, cardiovascular disease (CVD) continues to grow in prevalence, with CVDs being the leading cause of death globally. As clinicians work to treat CVDs, cardiology procedures continue to evolve as demand for minimally invasive surgery grows. GE HealthCare is committed to helping interventional cardiologists, vascular surgeons and other interventional specialists use image guidance technologies to their full potential by optimizing workflows and providing exceptional image quality to help clinicians provide quality care to their patients, while also enabling better clinical and operational outcomes. According to a survey of interventionalists, nearly 50% of interventional procedures are performed at working positions where clinicians have poor access to user interface functions and display.3 Designed to address these challenges, the new Allia IGS Pulse provides a personalized workspace that meets the operator’s specific needs and preferences. As part of its new image chain, the system features the first monopolar x-ray tube used to capture images for interventional procedures. This new tube is powerful, yet quieter than normal conversation4 to optimize the operating environment during a procedure. The small footprint of the new tube also helps clinicians reach steep angulation for better understanding of coronary artery anatomy, even with the 30cm detector configurations. The latest version of MyIQ technology incorporated into the system allows clinicians to select their favorite image look from four different image styles with just one click for a tailored experience at no additional dose. In the treatment of complex cardiovascular diseases, image quality and optimized dose management regardless of patient size are also important to clinicians. With Allia IGS Pulse, interventionalists are able to get exceptional image quality for large and bariatric patients with a BMI of greater than 30. The system’s reduced pulse width and unmatched X-ray peak power helps to decrease motion blur for better visualization of moving elements such as vessels and devices. To relieve clinicians and technologists of the complex task of optimizing image quality and dose during procedures, Allia IGS Pulse takes AutoRight, the company’s intelligent image chain leveraging AI, a step further with AutoRight PLUS - the next generation of the automation platform. With AutoRight PLUS, the system now optimizes seven parameters in real time, including Focal Spot Shape. By removing the burden of manual adjustment during procedures, clinicians can stay focused on the procedure and treatment of their patients. To further optimize dose along the image chain, a unique suite of tools is also available to help support dose efficiency, dose reduction and dose awareness. Since January 2023, Allia IGS Pulse has been in pilot operations at Clinique Pasteur - Toulouse in Toulouse, France. “At Clinique Pasteur in Toulouse, we perform thousands of interventional cardiology procedures each year,” says Dr. Nicolas Dumonteil, Interventional Cardiologist, Clinique Pasteur, Toulouse. “As an operator of the Allia IGS Pulse system, I felt a significant and real improvement in the imaging quality, as well as a significant reduction of this noise in my daily procedures which gave me great confidence and comfort in the operating room. The system is also quite adaptable and versatile to all of my daily situations and procedures – from percutaneous coronary interventions (PCIs) to other complex and structural ones.” says Dr Raphaël Philippart, Interventional Cardiologist, Clinique Pasteur, Toulouse. I saw a significant improvement in the image quality, especially with obese patients and complex angioplasties - where a good visibility of my guidewire, balloons and stents are particularly important. [Source – Business Wire] “Interventional cardiology procedures require exceptional image quality,” says Arnaud Marie – General Manager of Interventional for GE HealthCare. “I’m excited by the addition of Allia IGS Pulse to our interventional offerings because it addresses the very things clinicians continue to tell us present challenges in their day-to-day practice. By developing new features to further evolve our core platform, we’re helping to reduce complexity and improve the operating environment so that clinicians can have a personalized workspace that better enables them to keep their focus where it belongs – on their patients.”

Digital Healthcare

United Medical Uses Oracle Health EHR to Support Growth and Enhance Patient Care for Health Organizations

PR Newswire | October 23, 2023

United Medical, LLC, a multi-specialty ambulatory network with more than 225 full-service healthcare providers, has expanded its 20-year relationship with Oracle Health by another seven years. United Medical plans to deploy Oracle Health's electronic health record (EHR) at additional outpatient surgery centers and accountable care organizations within its network, providing a more intuitive platform to streamline workflows and processes for health practitioners. This helps bring financial, IT infrastructure, consulting services, and support together into one system to help provide more informed and coordinated care. said Kemal Erkan, CEO and President, United Medical. Our relationship with Oracle Health has allowed us to innovate and scale to new capabilities as demand for outpatient care is continuing to grow. This new strategic alignment will help create an easier path toward future growth opportunities as we ensure our practitioners have the latest and greatest technology to help improve their financial outcomes while remaining focused on top-tier patient care. [Source:PR Newswire] With Oracle Health's EHR integrated across its network, United Medical will use a single domain, central patient portal, and billing system where authorized caregivers and staff can easily and effectively manage the patient's care journey. The system will also enable practitioners to see and act on patient information from nearly any location, which will help enhance documentation, simplify follow-up, and improve patient adherence to health maintenance plans. "Teaming with networks like United Medical can help drive organizational efficiency that makes it easier for clinicians and staff to focus on patient care," said Travis Dalton executive vice president and general manager, Oracle Health. "With intelligent technology, Oracle Health is helping providers reduce costs, decrease burnout, and improve the patient experience."